Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group TrialAxel Le Cesne, Ole S. Nielsen, Jaap Verweij et al.|Journal of Clinical Oncology|2005Cited by 421
Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular targetJaap Verweij, Ole S. Nielsen, A. van Oosterom et al.|European Journal of Cancer|2003Cited by 403